Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (201-210 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|October 21, 2022
Squamous cell lung cancer: Current landscape and future therapeutic optionsSally C M Lau, Yuanwang Pan, Vamsidhar Velcheti, et al.
Cancer Cell|November 4, 2022
Selective advantage of epigenetically disrupted cancer cells via phenotypic inertiaIoannis Loukas, Fabrizio Simeoni, Marta Milan, et al.
Cancer Cell|November 4, 2022
Could SIRPA expression predict response to anti-PD-1 immunotherapy?Kristen Jogerst, Genevieve Boland
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Cancer Cell|September 30, 2022
Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasisDavid Y Takeda, Adam G Sowalsky
Cancer Cell|October 11, 2022
Cold exposure as anti-cancer therapyMariia Yuneva
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Cancer Cell|April 13, 2011
Chemokines and cancer: a fatal attractionRaffaella Bonecchi, Massimo Locati, Alberto Mantovani
Cancer Cell|April 13, 2011
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progressionAkihisa Fukuda, Sam C Wang, John P Morris, et al.
Pageof 410

Showing results (201-210 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|October 21, 2022
Squamous cell lung cancer: Current landscape and future therapeutic optionsSally C M Lau, Yuanwang Pan, Vamsidhar Velcheti, et al.
Cancer Cell|November 4, 2022
Selective advantage of epigenetically disrupted cancer cells via phenotypic inertiaIoannis Loukas, Fabrizio Simeoni, Marta Milan, et al.
Cancer Cell|November 4, 2022
Could SIRPA expression predict response to anti-PD-1 immunotherapy?Kristen Jogerst, Genevieve Boland
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Cancer Cell|September 30, 2022
Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasisDavid Y Takeda, Adam G Sowalsky
Cancer Cell|October 11, 2022
Cold exposure as anti-cancer therapyMariia Yuneva
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Cancer Cell|April 13, 2011
Chemokines and cancer: a fatal attractionRaffaella Bonecchi, Massimo Locati, Alberto Mantovani
Cancer Cell|April 13, 2011
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progressionAkihisa Fukuda, Sam C Wang, John P Morris, et al.
Pageof 410